Related Experiment Video

Updated: Jul 14, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Hodgkin's lymphoma in children aged 5 years or less - the United Kingdom experience

S Stoneham1, S Ashley, Ross Pinkerton

  • 1Department of Paediatric Haematology and Oncology, University College Hospital NHS Trust, 1st Floor, West Wing, 250, Euston Road, London NW1 2PG, UK.

European Journal of Cancer (Oxford, England : 1990)
|May 19, 2007
PubMed

Insights

Pediatric Hodgkin Lymphoma (HL) treatment in the UK showed that involved field radiotherapy (IF-RT) increased treatment failures and late side effects in young children. Combination chemotherapy was more common.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Clinical Trials

Background:

  • Hodgkin Lymphoma (HL) is a cancer of the lymphatic system.
  • Early diagnosis and treatment are crucial for pediatric cancer outcomes.
  • Understanding the natural history of HL in young children informs treatment strategies.

Purpose of the Study:

  • To describe the natural history of Hodgkin Lymphoma (HL) in children aged 5 years or younger at diagnosis.
  • To analyze treatment outcomes and late morbidities in this specific pediatric population.
  • To evaluate treatments administered between 1982 and 2000 in the United Kingdom.

Main Methods:

  • Retrospective analysis of 81 unselected children diagnosed with HL at age 5 or under.
  • Inclusion in United Kingdom Children's Cancer Study Group (UKCCSG) Hodgkin's trials HD1 and HD2.
  • Review of treatment modalities including chemotherapy and involved field radiotherapy (IF-RT).

Main Results:

  • 81% of patients presented with early-stage disease.
  • Combination chemotherapy was the most frequent primary treatment (65%).
  • Eighteen children (22%) experienced relapse after initial therapy.

Conclusions:

  • Involved field radiotherapy (IF-RT) was associated with higher rates of primary treatment failure.
  • IF-RT also correlated with increased late treatment-related morbidity in young children with HL.
  • These findings highlight potential risks of IF-RT in pediatric Hodgkin Lymphoma.
Abstract

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...